- Policy
- Insurance price ceiling reeval negotiations to end on Aug 18
- by Lee, Tak-Sun Aug 9, 2023 05:49am
- The pricing negotiations for items subject to revaluations of their insurance price ceiling in Korea are taking place from the 4th to the 18th of this month. The negotiations are expected to be completed within the deadline as the National Health Insurance Service has been discussing the measures with pharmaceutical companies in advance
- Policy
- When will domestic COVID-19 Txs be officially approved?
- by Lee, Hye-Kyung Aug 8, 2023 05:30am
- Voices calling for the approval of domestic COVID-19 treatments are rising. Petitions and heated discussions are being made on the free bulletin board of the Ministry of Food and Drug Safety’s website for the marketing authorization and accelerated review of homegrown COVID-19 treatments. The items that are receiving attention on the y
- Policy
- The price of 6 items of Choline alfoscerate is cut
- by Lee, Tak-Sun Aug 8, 2023 05:30am
- Despite the government's decision to limit reimbursement, the brain function-improving drug Choline Alfoscerate continues to come out with price cuts due to increased usage. It was found that 6 Choline Alfoscerate items were included in the PVA type Da negotiations this year as well. According to the industry on the 7th, negotiations were con
- Policy
- Cough Syrup and Synatura Syrup complete PVA negotiations
- by Lee, Tak-Sun Aug 8, 2023 05:30am
- Respiratory drugs such as Cough Syrup and Synatrua Syrup were found to have been added as subjects for drug pricing negotiations under the Price-Volume Agreement (PVA) this year. The use of the items had increased significantly last year due to the sharp increase in confirmed COVID-19 cases last year. According to industry sources on
- Policy
- Paxlovid and Dong-A’s Diosmin Powder were approved in July
- by Lee, Hye-Kyung Aug 7, 2023 05:23am
- The number of prescription drug approvals decreased significantly in July. The approvals, which had continuously increased from 70 in May to 93 in June, had fallen to record 29 in July. However, the drugs approved were nevertheless as significant as Pfizer Korea’s COVID-19 treatment ‘Paxlovid (nirmatrelvir, ritonavir)’, which had first bee
- Policy
- Sotyktu, the world's first TYK2I, received domestic approval
- by Lee, Hye-Kyung Aug 4, 2023 05:38am
- The Ministry of Food and Drug Safety (Minister Oh Yoo-Kyung) approved BMS Korea's new plaque psoriasis drug 'Sotyktu 6mg' on the 3rd. Psoriasis is a chronic skin disease caused by immune abnormalities, and plaque psoriasis is the most common form. Sotyktu treats psoriasis by selectively inhibiting 'tyrosine kinase-2 (TYK2)' receptors relat
- Policy
- Cancer immunotherapy Jemperli passes DREC review
- by Kim, Jung-Ju Aug 4, 2023 05:38am
- GSK Korea’s immno-oncology latecomer drug ‘Jemperli (dostarlimab)’ has passed its first step to reimbursement in Korea. On the other hand, Koselugo (selumetinib), AstraZeneca’s new drug for pediatric patients with neurofibromatosis type 1 (NF1), received a redicussion decision, warning of a bumpy journey ahead. The Health Insuranc
- Policy
- Animal drugs can be manufactured at human drug factories
- by Kang, Shin-Kook Aug 3, 2023 05:35am
- The manufacture of veterinary drugs are now allowed at manufacturing facilities that manufacture human drugs. The Ministry of Agriculture, Food and Rural Affairs recently announced the legislation of an amendment to the ‘Decree on the Facility Standards for Veterinary Pharmacies and Manufacturers, Importers, and Retailers of Veterinary D
- Policy
- Countdown to the Prime Minister’s Biohealth Committee
- by Lee, Jeong-Hwan Aug 3, 2023 05:35am
- Expected to be completed before the regular session of the National Assembly this year. The work of establishing a pan-governmental control tower dedicated to fostering Korea’s biopharmaceutical and healthcare industries has entered the countdown. The Ministry of Health and Welfare, along with the Office of the Prime Minister, plans to revi
- Policy
- MOHW ‘Cannnot defer price cuts made under PVA'
- by Lee, Jeong-Hwan Aug 2, 2023 05:25am
- The government has once again put its foot down and opposed to the request made by the pharmaceutical industry and the National Assembly to postpone drug price cuts applied under the Price-Volume Agreement (PVA) system until the exchange rate and prices stabilize. The government also added that it is working on an improvement plan for th
